Editorial Comment to Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone-sensitive prostate cancer

被引：2
|
作者：
Sakamoto, Shinichi [1 ]
机构：
[1] Chiba Univ, Dept Urol, Grad Sch Med, Chiba, Japan
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2016年 / 23卷 / 05期
关键词：
D O I：
10.1111/iju.13090
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：370 / 370
页数：1
相关论文
共 50 条
  • [1] Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone-sensitive prostate cancer
    Shiota, Masaki
    Eto, Masatoshi
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (05) : 360 - 369
  • [2] Current status and future perspectives of the managements of metastatic hormone-sensitive prostate cancer
    Naoki Matsumura
    Kazutoshi Fujita
    Mitsuhisa Nishimoto
    Takafumi Minami
    Hideo Tahara
    Kazuhiro Yoshimura
    Hirotsugu Uemura
    [J]. World Journal of Urology, 2023, 41 : 2063 - 2068
  • [3] Current status and future perspectives of the managements of metastatic hormone-sensitive prostate cancer
    Matsumura, Naoki
    Fujita, Kazutoshi
    Nishimoto, Mitsuhisa
    Minami, Takafumi
    Tahara, Hideo
    Yoshimura, Kazuhiro
    Uemura, Hirotsugu
    [J]. WORLD JOURNAL OF UROLOGY, 2023, 41 (08) : 2063 - 2068
  • [4] Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer Editorial Comment
    Taneja, Samir S.
    [J]. JOURNAL OF UROLOGY, 2016, 195 (01): : 94 - 94
  • [5] Novel androgen receptor inhibitors for metastatic hormone-sensitive prostate cancer: Current application and future perspectives
    Xia, Qi-Dong
    Zhang, Si-Han
    Zeng, Na
    Lu, Yu-Chao
    Qin, Bao-Long
    Wang, Shao-Gang
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2023, 168
  • [6] Current status of androgen deprivation therapy in hormone-sensitive prostate cancer
    Alvarez Rodriguez, Sara
    Alonso Gordoa, Teresa
    Burgos Revilla, Francisco Javier
    [J]. ARCHIVOS ESPANOLES DE UROLOGIA, 2018, 71 (03): : 247 - 257
  • [7] Real-world utilisation of upfront chemohormonal therapy in metastatic hormone-sensitive prostate cancer
    Kelly, R.
    Wong, S. S. L.
    Shapiro, J.
    Weickhardt, A. J.
    Parente, P.
    Azad, A.
    Uccellini, A.
    Torres, J.
    Parnis, F.
    Kwan, E.
    Brown, S.
    Steer, C.
    Warren, M.
    Gibbs, P.
    Anton, A.
    Tran, B.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S1498 - S1499
  • [8] The optimal upfront therapy in metastatic hormone-sensitive prostate cancer: A network meta-analysis
    Mutlu, Hasan
    Bozcuk, Hakan
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (02) : 394 - 402
  • [9] Treatment of primary cancer in metastatic hormone-sensitive prostate cancer
    Lim, Kylie Y. -Y.
    Alberto, Matthew
    Ranasinghe, Weranja
    [J]. CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2023, 17 (04) : 315 - 323
  • [10] Triple therapy in metastatic hormone-sensitive prostate cancer
    Tsaur, Igor
    Mirvald, Cristian
    Surcel, Cristian
    [J]. CURRENT OPINION IN UROLOGY, 2023, 33 (06) : 452 - 457
12345